Insights
Search Results
Client Highlights
9.19.25
Wilson Sonsini Advises Anysphere on Acquisition of Koala
Anysphere, the company behind the artificial intelligence coding application Cursor, acquired Koala, an AI-powered customer relationship management start-up. The acquisition brings Koala’s top engineers to Cursor to help build out a dedicated enterprise-readiness team. Wilson Sonsini Goodrich & Rosati advised Anysphere on the transaction.
Client Highlights
7.25.25
Wilson Sonsini Advises Revival on Strategic Partnership with Olympus
On July 25, 2025, Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech, announced a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions. The partnership is aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments. Wilson Sonsini Goodrich & Rosati advised Revival on the transaction and on fund matters related to the transaction.
Client Highlights
5.28.25
Wilson Sonsini Advises Zscaler on Acquisition of Red Canary
On May 27, 2025, Zscaler, Inc., the leader in cloud security, announced that it has signed a definitive agreement to acquire Red Canary, a recognized leader in managed detection and response (MDR) solutions. With the acquisition, Zscaler will further enhance its AI-powered security operations capabilities by integrating Red Canary’s MDR technology and expertise. Wilson Sonsini Goodrich & Rosati advised Zscaler on the transaction.
Client Highlights
5.09.25
Wilson Sonsini Advises AppLovin on Agreement to Sell Mobile Gaming Business to Tripledot
AppLovin Corporation, a leading marketing platform, announced the entry into a definitive agreement to sell its mobile gaming business to Tripledot for $400.0 million in cash consideration and equity consideration representing approximately 20% of Tripledot. The deal is anticipated to close in the second quarter of 2025, pending regulatory approvals. Wilson Sonsini Goodrich & Rosati advised AppLovin on the transaction.
Client Highlights
4.04.25
Wilson Sonsini Advises Skilljar on Acquisition by Gainsight
On April 2, 2025, Gainsight, a world-leading Customer Success platform that helps business drive growth by unifying the post-sales customer journey, acquired Skilljar, a leading Learning Management Software (LMS) provider for external training. Wilson Sonsini Goodrich & Rosati advised Skilljar on the transaction.
Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.
The Wilson Sonsini team that advised Skilljar on the transaction includes:
Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.
The Wilson Sonsini team that advised Skilljar on the transaction includes:
Client Highlights
12.20.24
Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio
On December 19, 2024, Aadi Bioscience announced that it had entered into an agreement to sell its commercial drug product FYARRO® to KAKEN Pharmaceutical for $100 million, an agreement to sell and issue $100 million of equity in a PIPE financing, and an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics, a global Contract Research, Development and Manufacturing Organization, and Hangzhou DAC, a global leader in ADC innovation.
Alerts
9.17.24
Heightened Obligations for Job Postings for Massachusetts-Based Roles
Beginning on July 31, 2025, Massachusetts will join a host of other states1 in requiring employers to provide detailed pay disclosures in public-facing and internal employee job postings pursuant to the recently passed Frances Perkins Workplace Equity Act (the Act). Specifically, the Act will require covered Massachusetts employers to disclose employee pay ranges in job postings and submit annual wage data reports to the Massachusetts Executive Office of Labor and Workforce Development (EOLWD).
Client Highlights
2.20.24
Wilson Sonsini Advises VIZIO on $2.3 Billion Acquisition by Walmart
On February 20, 2024, Walmart and VIZIO announced that they have entered into an agreement for Walmart to acquire VIZIO for $11.50 per share in cash, for an equity value of approximately $2.3 billion. Wilson Sonsini Goodrich & Rosati advised VIZIO on the transaction.